Insomnias. II. Pharmacological and psychotherapeutic treatment options
Abstract
The administration of benzodiazepine receptor agonists for periods of 3-4 weeks can be considered as evidence based for the treatment of insomnia. The off-label treatment of insomnia with sedating antidepressants or antipsychotics up to now has been subjected to far less rigorous evidence-based testing. In the meantime several randomized double-blind placebo-controlled studies indicate the effectiveness of sedating antidepressants for insomnia. Alternative medical treatments like the administration of melatonin or valerian are characterized by a heterogeneous database. On the contrary, cognitive behavioural therapy for insomnia (including psycho-education, relaxation, stimulus control, sleep restriction, cognitive therapy) is supported by an extensive database. This database indicates that cognitive behavioural methods are effective in the long term, thus emphasizing the importance of these strategies in the treatment of insomnia. Studies on the combination treatment of insomnia with hypnotics and cognitive behavioural therapy up to now were not able to show a superiority of the combination treatment versus monotreatment with behavioural therapy or hypnotics.
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Evaluating the Evidence Base of Melatonin, Light Exposure, Exercise, and Complementary and Alternative Medicine for Patients with Insomnia Disorder
- Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
- Influence of evening light exposure on polysomnographically assessed night-time sleep: A systematic review with meta-analysis
- Use of melatonin in children and adolescents with idiopathic chronic insomnia: a systematic review, meta-analysis, and clinical recommendation
- Significant potential of melatonin therapy in Parkinson’s disease – a meta-analysis of randomized controlled trials
- Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.